Log in to save to my catalogue

Preclinical Investigations of PM01183 (Lurbinectedin) as a Single Agent or in Combination with Other...

Preclinical Investigations of PM01183 (Lurbinectedin) as a Single Agent or in Combination with Other...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_1774172656

Preclinical Investigations of PM01183 (Lurbinectedin) as a Single Agent or in Combination with Other Anticancer Agents for Clear Cell Carcinoma of the Ovary

About this item

Full title

Preclinical Investigations of PM01183 (Lurbinectedin) as a Single Agent or in Combination with Other Anticancer Agents for Clear Cell Carcinoma of the Ovary

Publisher

United States: Public Library of Science

Journal title

PloS one, 2016-03, Vol.11 (3), p.e0151050-e0151050

Language

English

Formats

Publication information

Publisher

United States: Public Library of Science

Subjects

Subjects and topics

More information

Scope and Contents

Contents

The objective of this study was to evaluate the antitumor effects of lurbinectedin as a single agent or in combination with existing anticancer agents for clear cell carcinoma (CCC) of the ovary, which is regarded as an aggressive, chemoresistant, histological subtype.
Using human ovarian CCC cell lines, the antitumor effects of lurbinectedin, S...

Alternative Titles

Full title

Preclinical Investigations of PM01183 (Lurbinectedin) as a Single Agent or in Combination with Other Anticancer Agents for Clear Cell Carcinoma of the Ovary

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_plos_journals_1774172656

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_1774172656

Other Identifiers

ISSN

1932-6203

E-ISSN

1932-6203

DOI

10.1371/journal.pone.0151050

How to access this item